ANTIVIRAL THERAPY
抗病毒治疗
ISSN: 1359-6535
自引率: 3.9%
发文量: 18
被引量: 2489
影响因子: 1.677
通过率: 暂无数据
出版周期: 双月刊
审稿周期: 2
审稿费用: 0
版面费用: 暂无数据
年文章数: 18
国人发稿量: 15

投稿须知/期刊简介:

Published by International Medical Press. ISSN: 1359-6535.<br /><br />The field of antiviral therapy is expanding at an unprecedented rate. The tremendous expansion in drug screening and rational drug design brought about by the HIV pandemic, together with gathering interest in new viral targets&#x27; such as the hepatitis and papillomaviruses, means that more antiviral agents than ever are reaching clinical trials. Several journals now deal exclusively with the chemistry, design and pre-clinical development of antiviral agents. Previously, however, publications concerning clinical aspects of antiviral therapy have been dispersed among a wide range of different journals, making it increasingly difficult to keep abreast of this multidisciplinary field. Antiviral Therapy is the first international journal solely devoted to the clinical development and use of antiviral agents. It publishes original scientific papers in all therapeutic areas, including: results of clinical studies in all phases; viral diagnostics and individualization of antiviral therapy; study design issues in the clinical assessment of antivirals; antiviral drug safety and safety monitoring; mechanisms of resistance to antiviral agents; pharmacoepidemiology of viral diseases. Antiviral Therapy also features review articles, editorials, book reviews and a letters section to provide a forum for discussion. Antiviral Therapy is an official publication of the International Society for Antiviral Research

期刊描述简介:

The field of antiviral therapy is expanding at an unprecedented rate. The tremendous expansion in drug screening and rational drug design brought about by the HIV pandemic, together with gathering interest in new viral targets' such as the hepatitis and papillomaviruses, means that more antiviral agents than ever are reaching clinical trials. Several journals now deal exclusively with the chemistry, design and pre-clinical development of antiviral agents. Previously, however, publications concerning clinical aspects of antiviral therapy have been dispersed among a wide range of different journals, making it increasingly difficult to keep abreast of this multidisciplinary field. Antiviral Therapy is the first international journal solely devoted to the clinical development and use of antiviral agents. It publishes original scientific papers in all therapeutic areas, including: results of clinical studies in all phases; viral diagnostics and individualization of antiviral therapy; study design issues in the clinical assessment of antivirals; antiviral drug safety and safety monitoring; mechanisms of resistance to antiviral agents; pharmacoepidemiology of viral diseases. Antiviral Therapy also features review articles, editorials, book reviews and a letters section to provide a forum for discussion. Antiviral Therapy is an official publication of the International Society for Antiviral Research

最新论文
统计分析
是否有问题?您可以直接对期刊官方提问 提问

最近浏览

关于我们

zlive学术集成海量学术资源,融合人工智能、深度学习、大数据分析等技术,为科研工作者提供全面快捷的学术服务。在这里我们不忘初心,砥砺前行。

友情链接

联系我们

合作与服务

©2024 zlive学术声明使用前必读